Related Experiment Video
Updated: Jul 1, 2025
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
Management of stage III non-small-cell lung cancer: rays of hope
Floryane Kim1, Maxime Borgeaud1, Alfredo Addeo1
1Oncology Department, Geneva University Hospitals, 1205 Geneva, Switzerland.
Exploration of Targeted Anti-Tumor Therapy
|March 11, 2024
Summary
Stage III non-small-cell lung cancer (NSCLC) management is complex, involving multimodal treatments. Recent advancements include immune-checkpoint inhibitors and targeted therapies for locally advanced disease.
Area of Science:
- Oncology
- Pulmonology
Background:
- Non-small-cell lung cancer (NSCLC) is the leading cause of cancer death globally.
- Stage III NSCLC, representing 30% of cases, is locally advanced with a poor prognosis.
- Management of Stage III NSCLC is complex and requires multidisciplinary team discussion.
Purpose of the Study:
- To review the current landscape of Stage III NSCLC management.
- To highlight recent advancements, including immunotherapy and targeted therapies.
- To discuss critical issues such as resectability and treatment sequencing.
Main Methods:
- Review of current literature and clinical practices.
- Discussion of multimodal treatment approaches.
- Focus on immune-checkpoint inhibitors (ICIs) and targeted therapies.
Main Results:
- Stage III NSCLC is a heterogeneous group requiring tailored treatment strategies.
- Optimal treatment sequences and patient selection remain areas of debate.
- Incorporation of ICIs and targeted therapies shows promise in this setting.
Conclusions:
- Multimodal treatment with a maximalist approach is crucial for Stage III NSCLC.
- Further research is needed to optimize treatment sequencing and identify predictive biomarkers.
- Advancements in immunotherapy and targeted therapy are transforming the management of locally advanced NSCLC.
Keywords:
Non-small-cell lung cancerchemo-radiotherapymultidisciplinary managementperioperative immunotherapystage IIItargeted therapyMore Related Videos
Related Concept Videos
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
92
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
92
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
01:28Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
01:29Chronic Pancreatitis II: Collaborative Care
88
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
88